Physician profile
Tommy Bratcher
NPI 1356698328
$1,618.98
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $766 · 2022: $853.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $412.09 | 2021-2022 | |
| Glaxosmithkline, LLC. | $221.75 | 2021-2022 | |
| Mylan Specialty L.P. | $162.90 | 2021-2022 | |
| Lilly USA, LLC | $145.56 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $114.22 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $105.69 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $105.29 | 2021-2022 | |
| Novo Nordisk INC | $100.02 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $79.78 | 2022 | |
| Abbvie INC. | $52.17 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $31.42 | 2022 | |
| Pfizer INC. | $28.85 | 2021 | |
| Hologic Sales and Service, LLC | $17.09 | 2021 | |
| Amarin Pharma, INC. | $15.35 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.96 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $12.84 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tommy Bratcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.